These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15283213)

  • 41. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skin disorders in patients transplanted in childhood.
    Fortina AB; Piaserico S; Alaibac M; Caforio AL; Brandolisio L; Zacchello G; Zanon GF; Zancan L; Peserico A
    Transpl Int; 2005 Mar; 18(3):360-5. PubMed ID: 15730499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
    Ward HJ
    J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preface: 34th Congress of the Italian Transplantation Society (SITO).
    Risaliti A; Frascà G; Testasecca D; Benedetti A; Tavio M; Lorenzini I; Vivarelli M
    Transplant Proc; 2011 May; 43(4):949. PubMed ID: 21620024
    [No Abstract]   [Full Text] [Related]  

  • 45. [Organ transplantation: epidemiological and immunological aspects; principles of treatment and surveillance; complications and prognosis; ethical and legal aspects].
    Lebranchu Y; Sirinelli A; Wolf P; Mornex JF
    Rev Prat; 2004 Dec; 54(20):2295-304; quiz 2304. PubMed ID: 15736544
    [No Abstract]   [Full Text] [Related]  

  • 46. Treating ocular Myasthenia Gravis with inadequate evidence.
    Roach ES
    Arch Neurol; 2007 Dec; 64(12):1794-5. PubMed ID: 18071049
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.
    Taylor AL; Watson CJ; Bradley JA
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):23-46. PubMed ID: 16039869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transplant-associated hyperglycemia.
    Bloom RD; Crutchlow MF
    Transplant Rev (Orlando); 2008 Jan; 22(1):39-51. PubMed ID: 18631857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central serous chorioretinopathy after solid organ transplantation.
    Fawzi AA; Holland GN; Kreiger AE; Heckenlively JR; Arroyo JG; Cunningham ET
    Ophthalmology; 2006 May; 113(5):805-13.e5. PubMed ID: 16650676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review.
    Lekakis LJ; Macrinici V; Baraboutis IG; Mitchell B; Howard DS
    Am J Hematol; 2009 Apr; 84(4):243-6. PubMed ID: 19208419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coccidioidomycosis in patients who have undergone transplantation.
    Blair JE
    Ann N Y Acad Sci; 2007 Sep; 1111():365-76. PubMed ID: 17363431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinal complications in patients with solid organ or bone marrow transplantations.
    Chung H; Kim KH; Kim JG; Lee SY; Yoon YH
    Transplantation; 2007 Mar; 83(6):694-9. PubMed ID: 17414700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
    J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ocular Myasthenia Gravis treatment: the case against prednisone therapy and thymectomy.
    Gilbert ME; De Sousa EA; Savino PJ
    Arch Neurol; 2007 Dec; 64(12):1790-2. PubMed ID: 18071047
    [No Abstract]   [Full Text] [Related]  

  • 56. Tapping our immune potential to realise the ultimate goal.
    The Lancet Oncology
    Lancet Oncol; 2011 Dec; 12(13):1175. PubMed ID: 22123589
    [No Abstract]   [Full Text] [Related]  

  • 57. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
    Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Post-transplantation diabetes mellitus and its association with current immunodepressants].
    Rivera Valbuena JA; Zugasti Murillo A; Jara Albarrán A
    Med Clin (Barc); 2001 Sep; 117(9):353-6. PubMed ID: 11749909
    [No Abstract]   [Full Text] [Related]  

  • 59. Current world literature.
    Curr Opin Organ Transplant; 2009 Dec; 14(6):701-13. PubMed ID: 19920763
    [No Abstract]   [Full Text] [Related]  

  • 60. Cancers complicating organ transplantation.
    Penn I
    N Engl J Med; 1990 Dec; 323(25):1767-9. PubMed ID: 2247108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.